Wedbush Securities’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Wedbush Securities’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-50,000	Closed	–	–	1053
2019 Q1	$0	Buy	50,000 +32,600	+187%	+$8.3K	﹤0.01%	973
2018 Q4	$2K	Buy	17,400 +1,075	+7%	+$705	﹤0.01%	835
2018 Q3	$28K	Hold	16,325	–	–	﹤0.01%	884
2018 Q2	$28K	Buy	16,325 +1,925	+13%	+$3.33K	﹤0.01%	855
2018 Q1	$26K	Buy	+14,400	New	+$30.4K	﹤0.01%	804

Wedbush Securities's SGYP Position: Q2 2019 in Review

Wedbush Securities sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2019, closing a stake of 50,000 shares.

Wedbush Securities first reported a position in SGYP in Q1 2018 and held it in 5 quarters. The position peaked at $28K in Q3 2018. 2 funds tracked by Wall St. Rank hold SGYP as of Q2 2019.

Wedbush Securities reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q2 2019 after selling out during the quarter.
Wedbush Securities sold 50,000 Synergy Pharmaceuticals, Inc Common Stock shares in Q2 2019.
Wedbush Securities first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q1 2018 and held it in 5 quarters.
Wedbush Securities's Synergy Pharmaceuticals, Inc Common Stock position peaked at $28K in Q3 2018.
2 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2019.

Based on Wedbush Securities's 13F filing for Q2 2019, filed 1 Aug 2019.